toxicology

Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.

NAMs are increasingly used to de-risk preclinical development decisions, yet their broader impact on toxicology will depend on whether they are required or simply encouraged by regulators.

Learn how evidence-based enrichment strategies can better support laboratory animal welfare by promoting natural behaviors and reducing stress.

Learn how human-relevant models can be implemented for regulatory drug toxicity assessment.

Explore approaches to evaluate complex drug-induced liver injury and improve confidence in safety assessment.

Explore how advanced functional human organ models improve preclinical drug testing and toxicity evaluation.

How do forever chemicals impact cardiovascular health in postmenopausal women?

Clinical trial insights refine early-stage toxicology evaluations, yielding safer medicines.